Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Baihong is a leading Chinese biotechnology company specializing in regenerative medicine and tissue engineering, serving as a major industrialization hub for the Baihong Group. The company focuses on the development and commercialization of advanced tissue-engineered products, including China's first approved tissue-engineered skin for the treatment of burns and chronic wounds. Its portfolio extends into ophthalmology with artificial cornea research, orthopedics with bone repair materials, and a significant presence in the medical aesthetics market through regenerative skin care technologies. Led by prominent scientists in the field of stem cell research, Shandong Baihong integrates R&D, manufacturing, and clinical application to provide innovative solutions for functional tissue reconstruction.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 山东佰鸿.